News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Receiver Appointed Over Assets of Millenium Biologix Inc. and Authorized to Sell Skelite(TM) Technology


5/9/2007 1:16:24 PM

KINGSTON, ONTARIO -- (MARKET WIRE) -- May 09, 2007 -- Millenium Biologix Corporation ("Millenium" or the "Company") (TSX: MBC) today announced that it has received an Order from the Ontario Superior Court of Justice appointing Ernst & Young Inc. as receiver over certain of the Company's assets and authorizing the receiver to effect the sale of the Company's resorbable synthetic bone graft substitute technology, SkeliteO, in accordance with a previously announced agreement.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES